Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 17.3.2023CSL Behring GmbH (CSL)88206Alburex 20 (sol inf 1x100 ml/20 g (liek.skl.inj.))16.3.2023R
 17.3.2023G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))15.3.2023O
 17.3.2023Pfizer Europe MA EEIG (PFI-BE-3)94882SOLU-MEDROL 250 mg (plv iol 1x250 mg+4 ml solv. (1x dvojkomorová Act-O-Vial))21.3.2023Z
 16.3.2023POLICHEM S.A. (PLC)41145MACMIROR COMPLEX (crm vag 1x30 g (tuba Al))15.3.2023O
 16.3.2023Angelini Pharma Österreich GmbH (ANG-AT-1)7757AGlimbax (aer ora 1x15 ml (fľ.skl.hnedá))15.3.2023O
 16.3.2023Merck Sharp & Dohme B.V. (MSD-NL)40775CANCIDAS 70 mg prášok na infúzny koncentrát (plc ifc 1x70 mg (liek.inj.skl.))20.5.2023Z
 16.3.2023Merck Sharp & Dohme B.V. (MSD-NL)40776CANCIDAS 50 mg prášok na infúzny koncentrát (plc ifc 1x50 mg (liek.inj.skl.))20.5.2023Z
 16.3.2023Angelini Pharma Česká republika s.r.o. (AIP-2)28993ERDOMED 3,5 % (plu por 1x50 g (fľ.skl.jantárová))22.2.2023R
 16.3.2023Angelini Pharma Österreich GmbH (ANG-AT-1)3187CTANTUMGRIP 600 mg/10 mg prášok na perorálny roztok s pomarančovou príchuťou (plo por 10x600 mg/10 mg (vre.papier/Al/PE))16.3.2023Z
 16.3.2023Angelini Pharma Österreich GmbH (ANG-AT-1)3191CTANTUMGRIP 600 mg/10 mg prášok na perorálny roztok s citrónovou príchuťou (plo por 10x600 mg/10 mg (vre.papier/Al/PE))16.3.2023Z
 16.3.2023Viatris Healthcare Limited (VIM-1)1828AKombi-Kalz 500 mg/800 IU filmom obalené tablety (tbl flm 30x500 mg/800 IU (obal HDPE))16.3.2023O
 16.3.2023Berlin-Chemie AG (BCE)59166Espumisan L (gte por 1x30 ml (fľ.skl.jantárová))16.3.2023O
 16.3.2023Teva B.V. (TEV-NL-4)95214Ramipril H 2,5 mg/12,5 mg Actavis (tbl 30x2,5 mg/12,5 mg (blis.Al/Al))14.3.2023O
 16.3.2023Teva Czech Industries s.r.o. (TEV-CZ-2)10185EQUORAL 100 mg (cps mol 50x100 mg (blis.Al/Al))15.3.2023O
 16.3.2023Baxalta Innovations GmbH (BXA)85677FEIBA 50 U/ml (plv iio 1x1000 U+20 ml solv.(liek.inj.skl.+prísl.))15.3.2023Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)